Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

2.

PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.

Villar J, Quadri HS, Song I, Tomita Y, Tirado OM, Notario V.

Cancer Res. 2009 Jan 1;69(1):102-10. doi: 10.1158/0008-5472.CAN-08-2922.

3.
5.

Protein kinase C and other diacylglycerol effectors in cancer.

Griner EM, Kazanietz MG.

Nat Rev Cancer. 2007 Apr;7(4):281-94. Review.

PMID:
17384583
6.

PKC inhibitor Go6976 induces mitosis and enhances doxorubicin-paclitaxel cytotoxicity in urinary bladder carcinoma cells.

Aaltonen V, Koivunen J, Laato M, Peltonen J.

Cancer Lett. 2007 Aug 8;253(1):97-107. Epub 2007 Feb 22.

PMID:
17320279
7.

The multiple faces of caveolae.

Parton RG, Simons K.

Nat Rev Mol Cell Biol. 2007 Mar;8(3):185-94. Review.

PMID:
17318224
8.

Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence.

Karam JA, Lotan Y, Roehrborn CG, Ashfaq R, Karakiewicz PI, Shariat SF.

Prostate. 2007 May 1;67(6):614-22.

PMID:
17299799
9.

Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity.

Shajahan AN, Wang A, Decker M, Minshall RD, Liu MC, Clarke R.

J Biol Chem. 2007 Feb 23;282(8):5934-43. Epub 2006 Dec 26.

10.

Cancer metastasis: building a framework.

Gupta GP, Massagué J.

Cell. 2006 Nov 17;127(4):679-95. Review.

11.

Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.

Tirado OM, Mateo-Lozano S, Villar J, Dettin LE, Llort A, Gallego S, Ban J, Kovar H, Notario V.

Cancer Res. 2006 Oct 15;66(20):9937-47.

12.

Caveolin-1 in meningiomas: expression and clinico-pathological correlations.

Barresi V, Cerasoli S, Paioli G, Vitarelli E, Giuffrè G, Guiducci G, Tuccari G, Barresi G.

Acta Neuropathol. 2006 Nov;112(5):617-26. Epub 2006 Jul 19.

PMID:
16850311
13.

Ewing's sarcoma family of tumors: current management.

Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H.

Oncologist. 2006 May;11(5):503-19. Review.

14.

Potentiation of neuroblastoma metastasis by loss of caspase-8.

Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ, Lahti JM, Cheresh DA.

Nature. 2006 Jan 5;439(7072):95-9.

PMID:
16397500
15.

Roscovitine is an effective inducer of apoptosis of Ewing's sarcoma family tumor cells in vitro and in vivo.

Tirado OM, Mateo-Lozano S, Notario V.

Cancer Res. 2005 Oct 15;65(20):9320-7.

16.

Treatment approaches for metastatic Ewing's sarcoma: a review of the literature.

Hendershot E.

J Pediatr Oncol Nurs. 2005 Nov-Dec;22(6):339-52. Review.

PMID:
16216896
17.

Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy.

Selleri S, Arnaboldi F, Palazzo M, Hussein U, Balsari A, Rumio C.

Br J Dermatol. 2005 Sep;153(3):506-13.

PMID:
16120134
18.

Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma.

Nakatani K, Wada T, Nakamura M, Uzawa K, Tanzawa H, Fujita S.

J Cancer Res Clin Oncol. 2005 Jul;131(7):445-52. Epub 2005 Apr 26.

PMID:
15856296
19.

Survival after recurrence of Ewing's sarcoma family of tumors.

Barker LM, Pendergrass TW, Sanders JE, Hawkins DS.

J Clin Oncol. 2005 Jul 1;23(19):4354-62. Epub 2005 Mar 21.

PMID:
15781881
20.

Caveolin-1 in oncogenic transformation, cancer, and metastasis.

Williams TM, Lisanti MP.

Am J Physiol Cell Physiol. 2005 Mar;288(3):C494-506. Review.

Supplemental Content

Support Center